Moneycontrol
HomeNewsBusinessMarkets‘Allocate 30%-40% of investable corpus now at the current levels and rest on declines’

‘Allocate 30%-40% of investable corpus now at the current levels and rest on declines’

In our opinion, it is an excellent time to build a long term portfolio as many fundamentally sound counters are available at a good bargain, says Gurpreet Sidana.

April 13, 2020 / 12:39 IST
Story continues below Advertisement

For those looking to build a fresh portfolio, we would suggest allocating 30-40 percent of their investable corpus at the current levels and wait for further correction or clarity over the market direction, Gurpreet Sidana, Chief Operating Officer, Religare Broking Ltd, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

Q) What is be your advice to investors now - lump sum or staggered approach in direct equities or mutual funds?

A) It is a tough situation, not only for the Indian economy but for the markets across the globe. It’s different from earlier downturns as it is triggered by a pandemic and the exact impact or peak can’t be quantified yet.

Story continues below Advertisement

However, this is also true that the market emerges much stronger and garners exceptional returns for those who utilise these corrections to accumulate quality companies with a long-term investment horizon.

Maybe a first-timer is still contemplating over his investment plan but a smart investor knows this well and will thus try to exploit this opportunity.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show